FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company. The action concerns the ZYPREXA ZYDIS product and its…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ZYPREXA ZYDIS (olanzapine)

Snippet

SUPPL AP for ZYPREXA ZYDIS (OLANZAPINE)